Primary Care Diabetes
Volume 3, Issue 4 , Pages 239-244 , November 2009

Perceptions of heart attack risk amongst individuals with diabetes

  • Hermione C. Price

      Affiliations

    • Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 01865 857255; fax: +44 01865 857241.
  • ,
  • Christina Dudley

      Affiliations

    • Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, United Kingdom
    • The NIHR Oxford Biomedical Research Centre, United Kingdom
  • ,
  • Beryl Barrow

      Affiliations

    • Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, United Kingdom
    • The NIHR Oxford Biomedical Research Centre, United Kingdom
  • ,
  • Simon J. Griffin

      Affiliations

    • MRC Epidemiology Unit, Cambridge, United Kingdom
  • ,
  • Rury R. Holman

      Affiliations

    • Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, United Kingdom

Received 10 July 2009 ,Revised 1 September 2009 ,Accepted 30 September 2009.

References 

  1. Centers for Disease Control and Prevention . Centers for Disease Control and Prevention Diabetes Surveillance Report. 1999;
  2. Stamler JVO, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16:434–444
  3. Asimakopoulou K, Skinner T, Fox C, Spimpolo J, Marsh S. Risk communication in type 2 diabetes (T2D): the effects of using different time-frames of communicating risk of coronary heart disease (CHD) and stroke on patients’ understanding and memory of these risks. Diabetic Medicine. 2007;24:95
  4. Bhargava A, O'Sullivan E, O’Callaghan M, et al. Awareness of risk for cardiovascular disease in Irish patients with diabetes mellitus. Diabetic Medicine. 2007;24:95
  5. Carroll C, Naylor E, Marsden P, Dornan T . How do people with type 2 diabetes perceive and respond to cardiovascular risk?. Diabetic Medicine. 2003;20:355–360
  6. Holman R, Paul S, Bethel M, Matthews D, Neil H. 10-year follow-up of intensive glucose control in type 2 diabetes. New England Journal of Medicine. 2008;359:1577–1589
  7. Ray K, Seshasai S, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. The Lancet. 2009;373:1765–1772
  8. Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. The Lancet. 2004;364:685–696
  9. Heart Protection Study Collaborative Group . MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. The Lancet. 2003;361:2005–2016
  10. Hansson L, Zanchetti A, Carruthers S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. The Lancet. 1998;351:1755–1762
  11. United Kingdom Prospective Diabetes Study Group . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713
  12. Batty G, Shipley M, Marmot M, Smith G. Physical activity and cause-specific mortality in men with type 2 diabetes/impaired glucose tolerance: evidence from the Whitehall study. Diabetic Medicine. 2002;19:580–588
  13. Durack-Bown I, Giral P, d’Ivernois J, et al. Patients’ and physicians’ perceptions and experience of hypercholesterolaemia: a qualitative study. British Journal of General Practice. 2003;53:851–857
  14. Davison C, Davey-Smith G, Frankel S . Lay epidemiology and the prevention paradox: the implications of coronary candidacy for health education. Sociology of Health & Illness. 1991;13:1–19
  15. Davison C, Frankel S, Smith G. The limits of lifestyle: re-assessing ‘fatalism’ in the popular culture of illness prevention. Social Science & Medicine. 1992;34:675–685
  16. National Institute for Health and Clinical Excellence . Statins for the Prevention of Cardiovascular Disease. 2006;
  17. Farrimond H, Saukko P, Qureshi N, Evans P. Making sense of being at ‘high risk’ of coronary heart disease within primary prevention. Psychology & Health. 2008;
  18. Hardeman W, Kinmonth AL, Michie S, Sutton S for the ProActive Project Team. Impact of a physical activity intervention program on cognitive predictors of behaviour among adults at risk of type 2 diabetes (ProActive randomised controlled trial). International Journal of Behavioral Nutrition and Physical Activity. 2009;6:16
  19. Ransdell LB, Detling N, Hildebrand K, Lau P, Moyer-Mileur L, Shultz B. Can physical activity interventions change perceived exercise benefits and barriers?. American Journal of Health Studies. 2004;19:195–204
  20. Merz C, Buse J, Tuncer D, Twillman G . Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes. Journal of the American College of Cardiology. 2002;40:1877–1881
  21. Davis J. Understanding the meanings of children: a reflexive process. Children & Society. 1999;12:325–335
  22. Price HC, Dudley C, Barrow B, Kennedy I, Griffin SJ, Holman RR . Use of focus groups to develop methods to communicate cardiovascular disesase risk and potential for risk reduction to people with type 2 diabetes. Family Practice. 2009;26(5):351–358
  23. Price H, Tucker L, Griffin S, Holman R . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD. A Pilot 2×2 Factorial “Understanding Risk” Trial. Cardiovascular Diabetology. 2008;7:21

PII: S1751-9918(09)00093-X

doi: 10.1016/j.pcd.2009.09.005

Primary Care Diabetes
Volume 3, Issue 4 , Pages 239-244 , November 2009